Related references
Note: Only part of the references are listed.METTL3-mediated m6A mRNA contributes to the resistance of carbon-ion radiotherapy in non-small-cell lung cancer
Xiaofeng Xu et al.
CANCER SCIENCE (2023)
The Role of RNA m6A Modification in Cancer Glycolytic Reprogramming
Yuanqi Li et al.
CURRENT GENE THERAPY (2023)
Biological roles of adenine methylation in RNA
Konstantinos Boulias et al.
NATURE REVIEWS GENETICS (2023)
N6-methyladenosine reader YTHDF family in biological processes: Structures, roles, and mechanisms
Lin Chen et al.
FRONTIERS IN IMMUNOLOGY (2023)
Research progress of traditional Chinese medicine as sensitizer in reversing chemoresistance of colorectal cancer
Xiang Lin et al.
FRONTIERS IN ONCOLOGY (2023)
METTL16 drives leukemogenesis and leukemia stem cell self-renewal by reprogramming BCAA metabolism
Li Han et al.
CELL STEM CELL (2023)
Emerging roles of m6A RNA modification in cancer therapeutic resistance
Wei-Wei Liu et al.
EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2023)
Combination of Compound Kushen Injection and cisplatin shows synergistic antitumor activity in p53-R273H/P309S mutant colorectal cancer cells through inducing apoptosis
Xingkang Wu et al.
JOURNAL OF ETHNOPHARMACOLOGY (2022)
FTO suppresses glycolysis and growth of papillary thyroid cancer via decreasing stability of APOE mRNA in an N6-methyladenosine-dependent manner
Jiapeng Huang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2022)
Functions, mechanisms, and therapeutic implications of METTL14 in human cancer
Qian Guan et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2022)
RNA demethylase ALKBH5 in cancer: from mechanisms to therapeutic potential
Jianwei Qu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2022)
m6A modification: recent advances, anticancer targeted drug discovery and beyond
Li-Juan Deng et al.
MOLECULAR CANCER (2022)
METTL14-mediated m6A modification of circORC5 suppresses gastric cancer progression by regulating miR-30c-2-3p/AKT1S1 axis
Hui-Ning Fan et al.
MOLECULAR CANCER (2022)
METTL16 exerts an m(6)A-independent function to facilitate translation and tumorigenesis
Rui Su et al.
NATURE CELL BIOLOGY (2022)
Baicalin suppresses the progression of Type 2 diabetes-induced liver tumor through regulating METTL3/m6A/HKDC1 axis and downstream p-JAK2/STAT1/clevaged Capase3 pathway
Hongpeng Jiang et al.
PHYTOMEDICINE (2022)
Glutathione-Bioimprinted Nanoparticles Targeting of N6-methyladenosine FTO Demethylase as a Strategy against Leukemic Stem Cells
Kunxia Cao et al.
SMALL (2022)
Emerging strategies for the improvement of chemotherapy in bladder cancer: Current knowledge and future perspectives
Sen Liu et al.
JOURNAL OF ADVANCED RESEARCH (2022)
Methyltransferase-like 3 upregulation is involved in the chemoresistance of non-small cell lung cancer
Lin Shi et al.
ANNALS OF TRANSLATIONAL MEDICINE (2022)
p53 m6A modulation sensitizes hepatocellular carcinoma to apatinib through apoptosis
Weiwei Ke et al.
APOPTOSIS (2022)
METTL14-mediated N6-methyladenosine modification of ITGB4 mRNA inhibits metastasis of clear cell renal cell carcinoma
Zhuonan Liu et al.
CELL COMMUNICATION AND SIGNALING (2022)
FTO m6A Demethylase in Obesity and Cancer: Implications and Underlying Molecular Mechanisms
Sarah Kassem Azzam et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
METTL3/IGF2BP3 axis inhibits tumor immune surveillance by upregulating N6-methyladenosine modification of PD-L1 mRNA in breast cancer
Weijun Wan et al.
MOLECULAR CANCER (2022)
Interaction of lncRNA MIR100HG with hnRNPA2B1 facilitates m6A-dependent stabilization of TCF7L2 mRNA and colorectal cancer progression
Hao Liu et al.
MOLECULAR CANCER (2022)
Lactylation-driven METTL3-mediated RNA m6A modification promotes immunosuppression of tumor-infiltrating myeloid cells
Jia Xiong et al.
MOLECULAR CELL (2022)
RNA N6-methyladenosine demethylase FTO promotes pancreatic cancer progression by inducing the autocrine activity of PDGFC in an m6A-YTHDF2-dependent manner
Zhen Tan et al.
ONCOGENE (2022)
The IGF2BP family of RNA binding proteins links epitranscriptomics to cancer
Deepthi Ramesh-Kumar et al.
SEMINARS IN CANCER BIOLOGY (2022)
A novel inhibitor of N6-methyladenosine demethylase FTO induces mRNA methylation and shows anti-cancer activities
Guoyou Xie et al.
ACTA PHARMACEUTICA SINICA B (2022)
m6A binding protein YTHDF2 in cancer
Xiaomin Chen et al.
EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2022)
Non-Small Cell Lung Cancer Targeted Therapy: Drugs and Mechanisms of Drug Resistance
Jiajia Wu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Biological and pharmacological roles of m6A modifications in cancer drug resistance
Zaoqu Liu et al.
MOLECULAR CANCER (2022)
Targeted therapy for breast cancer: An overview of drug classes and outcomes
Aaron T. Jacobs et al.
BIOCHEMICAL PHARMACOLOGY (2022)
Anesthetic propofol enhances cisplatin-sensitivity of non-small cell lung cancer cells through N6-methyladenosine-dependently regulating the miR-486-5p/RAP1-NF-κB axis
Quan Ling et al.
BMC CANCER (2022)
METTL16 promotes hepatocellular carcinoma progression through downregulating RAB11B-AS1 in an m(6)A-dependent manner
Yun-Zhang Dai et al.
CELLULAR & MOLECULAR BIOLOGY LETTERS (2022)
METTL3 Inhibits Antitumor Immunity by Targeting m6A-BHLHE41-CXCL1/CXCR2 Axis to Promote Colorectal Cancer
Huarong Chen et al.
GASTROENTEROLOGY (2022)
Discovery of novel mRNA demethylase FTO inhibitors against esophageal cancer
Bo Qin et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2022)
Structure-Activity Relationships and Antileukemia Effects of the Tricyclic Benzoic Acid FTO Inhibitors
Zeyu Liu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2022)
Rational Design and Optimization m6A-RNA Demethylase FTO Inhibitors as Anticancer Agents
Sarah Huff et al.
JOURNAL OF MEDICINAL CHEMISTRY (2022)
Decreased expression of programmed death ligand-L1 by seven in absentia homolog 2 in cholangiocarcinoma enhances T-cell-mediated antitumor activity
Hao Zheng et al.
FRONTIERS IN IMMUNOLOGY (2022)
Mutual regulation between N6-methyladenosine (m6A) modification and circular RNAs in cancer: impacts on therapeutic resistance
Hong Lin et al.
MOLECULAR CANCER (2022)
The role, mechanism, and application of RNA methyltransferase METTL14 in gastrointestinal cancer
Bin Shi et al.
MOLECULAR CANCER (2022)
Adverse skin reactions induced by sintilimab in advanced lung squamous carcinoma: a case report and review of the literature
Juan Yan et al.
ANNALS OF TRANSLATIONAL MEDICINE (2022)
Role of m6A writers, erasers and readers in cancer
Zhen Fang et al.
EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2022)
Exosome-based strategies for diagnosis and therapy of glioma cancer
Mohsen Karami Fath et al.
CANCER CELL INTERNATIONAL (2022)
Mesenchymal stem cell-derived exosomes in cancer therapy resistance: recent advances and therapeutic potential
Zhengjun Lin et al.
MOLECULAR CANCER (2022)
The role of PD-1/PD-L1 and application of immune-checkpoint inhibitors in human cancers
Qing Tang et al.
FRONTIERS IN IMMUNOLOGY (2022)
The potential effects and mechanisms of Gegen Qinlian Decoction in oxaliplatin-resistant colorectal cancer based on network pharmacology
Xiang Lin et al.
HELIYON (2022)
N1-methyladenosine modification in cancer biology: Current status and future perspectives
Jiexin Li et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2022)
METTL16 antagonizes MRE11-mediated DNA end resection and confers synthetic lethality to PARP inhibition in pancreatic ductal adenocarcinoma
Xiangyu Zeng et al.
NATURE CANCER (2022)
RNA N6 -methyladenosine reader YTHDC1 is essential for TGF-beta-mediated metastasis of triple negative breast cancer
Brandon Tan et al.
THERANOSTICS (2022)
FTO in cancer: functions, molecular mechanisms, and therapeutic implications
Yangchan Li et al.
TRENDS IN CANCER (2022)
The role of Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs) as m6A readers in cancer
Chao-Yue Sun et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2022)
Therapy resistance: opportunities created by adaptive responses to targeted therapies in cancer
Marilyne Labrie et al.
NATURE REVIEWS CANCER (2022)
ALKBH5 Inhibited Cell Proliferation and Sensitized Bladder Cancer Cells to Cisplatin by m6A-CK2α-Mediated Glycolysis
Hao Yu et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2021)
m6A-RNA Demethylase FTO Inhibitors Impair Self-Renewal in Glioblastoma Stem Cells
Sarah Huff et al.
ACS CHEMICAL BIOLOGY (2021)
Omeprazole improves chemosensitivity of gastric cancer cells by m(6)A demethylase FTO-mediated activation of mTORC1 and DDIT3 up-regulation
Shuitu Feng et al.
BIOSCIENCE REPORTS (2021)
Circ0008399 Interaction with WTAP Promotes Assembly and Activity of the m6A Methyltransferase Complex and Promotes Cisplatin Resistance in Bladder Cancer
Wenjie Wei et al.
CANCER RESEARCH (2021)
Anticancer drug resistance: An update and perspective
Ruth Nussinov et al.
DRUG RESISTANCE UPDATES (2021)
The m6A RNA Demethylase ALKBH5 Promotes Radioresistance and Invasion Capability of Glioma Stem Cells
Aline Kowalski-Chauvel et al.
CANCERS (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
METTL16, Methyltransferase-Like Protein 16: Current Insights into Structure and Function
Agnieszka Ruszkowska
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
RBM15 facilitates laryngeal squamous cell carcinoma progression by regulating TMBIM6 stability through IGF2BP3 dependent
Xin Wang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)
RNA methylation and cancer treatment
Baochen Yang et al.
PHARMACOLOGICAL RESEARCH (2021)
Exosomal Delivery of FTO Confers Gefitinib Resistance to Recipient Cells through ABCC10 Regulation in an m6A-dependent Manner
Peng Xiao et al.
MOLECULAR CANCER RESEARCH (2021)
RNA m6A methylation orchestrates cancer growth and metastasis via macrophage reprogramming
Huilong Yin et al.
NATURE COMMUNICATIONS (2021)
Effects of Quercetin on the Efficacy of Various Chemotherapeutic Drugs in Cervical Cancer Cells
Wenbin Xu et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2021)
Role of m6A methyltransferase component VIRMA in multiple human cancers (Review)
Wei Zhu et al.
CANCER CELL INTERNATIONAL (2021)
Tumors exploit FTO-mediated regulation of glycolytic metabolism to evade immune surveillance
Yi Liu et al.
CELL METABOLISM (2021)
The roles and mechanisms of the m6A reader protein YTHDF1 in tumor biology and human diseases
Zuyao Chen et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2021)
Curcumin prevents obesity by targeting TRAF4-induced ubiquitylation in m6A-dependent manner
Yushi Chen et al.
EMBO REPORTS (2021)
Berberine Suppresses Stemness and Tumorigenicity of Colorectal Cancer Stem-Like Cells by Inhibiting m6A Methylation
Ziyi Zhao et al.
FRONTIERS IN ONCOLOGY (2021)
Sec62 promotes stemness and chemoresistance of human colorectal cancer through activating Wnt/β-catenin pathway
Xiaofeng Liu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)
Novel Small Molecule RNA m6A Demethylase AlkBH5 Inhibitors for Treating Cancer
Ram W. Sabnis
ACS Medicinal Chemistry Letters (2021)
Rational Design of Novel Anticancer Small-Molecule RNA m6A Demethylase ALKBH5 Inhibitors
Simona Selberg et al.
ACS OMEGA (2021)
The m6A methyltransferase METTL3 regulates autophagy and sensitivity to cisplatin by targeting ATG5 in seminoma
Hanfei Chen et al.
TRANSLATIONAL ANDROLOGY AND UROLOGY (2021)
被撤回的出版物: LncRNA LBX2-AS1 promotes colorectal cancer progression and 5-fluorouracil resistance (Retracted article. See vol. 23, 2023)
Yu-Nan Ma et al.
CANCER CELL INTERNATIONAL (2021)
M(6)A Demethylase ALKBH5 Regulates PD-L1 Expression and Tumor Immunoenvironment in Intrahepatic Cholangiocarcinoma
Xinyao Qiu et al.
CANCER RESEARCH (2021)
Long noncoding RNA just proximal to X-inactive specific transcript facilitates aerobic glycolysis and temozolomide chemoresistance by promoting stability of PDK1 mRNA in an m6A-dependent manner in glioblastoma multiforme cells
Xu Dong Li et al.
CANCER SCIENCE (2021)
ATF3 Modulates the Resistance of Breast Cancer Cells to Tamoxifen through an N6-Methyladenosine-Based Epitranscriptomic Mechanism
Xiaochuan Liu et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2021)
METTL3 Inhibitors for Epitranscriptomic Modulation of Cellular Processes
Elena V. Moroz-Omori et al.
CHEMMEDCHEM (2021)
ALKBH5-HOXA10 loop-mediated JAK2 m6A demethylation and cisplatin resistance in epithelial ovarian cancer
Sipei Nie et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)
1,4,9-Triazaspiro[5.5]undecan-2-one Derivatives as Potent and Selective METTL3 Inhibitors
Aymeric Dolbois et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Mechanism of Drug Tolerant Persister Cancer Cells: The Landscape and Clinical Implication for Therapy
Masashi Mikubo et al.
JOURNAL OF THORACIC ONCOLOGY (2021)
Mining for METTL3 inhibitors to suppress cancer
Jiazhi Li et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2021)
Aidi injection, a traditional Chinese medicine extract, reverses Gefitinib resistance in non-small cell lung cancer cells
Riya Biswas et al.
EUROPEAN JOURNAL OF INTEGRATIVE MEDICINE (2021)
EMP3 negatively modulates breast cancer cell DNA replication, DNA damage repair, and stem-like properties
Kailing Zhou et al.
CELL DEATH & DISEASE (2021)
Upregulation of lncRNA NIFK-AS1 in hepatocellular carcinoma by m6A methylation promotes disease progression and sorafenib resistance
Yi-tian Chen et al.
HUMAN CELL (2021)
A methyltransferase-like 14/miR-99a-5p/tribble 2 positive feedback circuit promotes cancer stem cell persistence and radioresistance via histone deacetylase 2-mediated epigenetic modulation in esophageal squamous cell carcinoma
Zhenchuan Liu et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2021)
The role of m6A modification in the biological functions and diseases
Xiulin Jiang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Saikosaponin D exhibits anti-leukemic activity by targeting FTO/m(6)A signaling
Kaiju Sun et al.
THERANOSTICS (2021)
Methylation of adenosine at the N6 position post-transcriptionally regulates hepatic P450s expression
Masataka Nakano et al.
BIOCHEMICAL PHARMACOLOGY (2020)
3D proteome-wide scale screening and activity evaluation of a new ALKBH5 inhibitor in U87 glioblastoma cell line
Alessio Malacrida et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2020)
m6A demethylase ALKBH5 inhibits pancreatic cancer tumorigenesis by decreasing WIF-1 RNA methylation and mediating Wnt signaling
Bo Tang et al.
MOLECULAR CANCER (2020)
METTL14 suppresses proliferation and metastasis of colorectal cancer by down-regulating oncogenic long non-coding RNA XIST
Xiao Yang et al.
MOLECULAR CANCER (2020)
Small-Molecule Inhibitors of METTL3, the Major Human Epitranscriptomic Writer
Rajiv K. Bedi et al.
CHEMMEDCHEM (2020)
RNA m6A methylation regulates sorafenib resistance in liver cancer through FOXO3-mediated autophagy
Ziyou Lin et al.
EMBO JOURNAL (2020)
m6A-binding proteins: the emerging crucial performers in epigenetics
Yanchun Zhao et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Emerging role of RNA methyltransferase METTL3 in gastrointestinal cancer
Qiang Wang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
TRIM11 facilitates chemoresistance in nasopharyngeal carcinoma by activating the β-catenin/ABCC9 axis via p62-selective autophagic degradation of Daple
Runa Zhang et al.
ONCOGENESIS (2020)
The potential role of RNA N6-methyladenosine in Cancer progression
Tianyi Wang et al.
MOLECULAR CANCER (2020)
Targeting FTO Suppresses Cancer Stem Cell Maintenance and Immune Evasion
Rui Su et al.
CANCER CELL (2020)
m6A Reader YTHDC2 Promotes Radiotherapy Resistance of Nasopharyngeal Carcinoma via Activating IGF1R/AKT/S6 Signaling Axis
Jun-Ju He et al.
FRONTIERS IN ONCOLOGY (2020)
Identification of Specific N6-Methyladenosine RNA Demethylase FTO Inhibitors by Single-Quantum-Dot-Based FRET Nanosensors
Yan Zhang et al.
ANALYTICAL CHEMISTRY (2020)
METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer
Xiaoxiang Chen et al.
MOLECULAR CANCER (2020)
m6A RNA methyltransferases METTL3/14 regulate immune responses to anti-PD-1 therapy
Lingling Wang et al.
EMBO JOURNAL (2020)
ALKBH5 regulates anti-PD-1 therapy response by modulating lactate and suppressive immune cell accumulation in tumor microenvironment
Na Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
METTL3 potentiates resistance to cisplatin through m6A modification of TFAP2C in seminoma
Jingchao Wei et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
Roles of METTL3 in cancer: mechanisms and therapeutic targeting
Chengwu Zeng et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Study and analysis of antitumor resistance mechanism of PD1/PD-L1 immune checkpoint blocker
Zhengyi Wang et al.
CANCER MEDICINE (2020)
Colorectal Cancer Immunotherapy: Options and Strategies
Nor Adzimah Johdi et al.
FRONTIERS IN IMMUNOLOGY (2020)
Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance
Yihan Yao et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2020)
Surmounting cancer drug resistance: New insights from the perspective of N6-methyladenosine RNA modification
Bowen Li et al.
DRUG RESISTANCE UPDATES (2020)
Clinical application and mechanism of traditional Chinese medicine in treatment of lung cancer
Xiao-Lin Su et al.
CHINESE MEDICAL JOURNAL (2020)
m6A RNA methylation-mediated HNF3γ reduction renders hepatocellular carcinoma dedifferentiation and sorafenib resistance
Tengfei Zhou et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
The mechanism of m6A methyltransferase METTL3-mediated autophagy in reversing gefitinib resistance in NSCLC cells by β-elemene
Shuiping Liu et al.
CELL DEATH & DISEASE (2020)
Chidamide increases the sensitivity of Non-small Cell Lung Cancer to Crizotinib by decreasing c-MET mRNA methylation
Nan Ding et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2020)
N6-methyladenosine-induced ERR. triggers chemoresistance of cancer cells through upregulation of ABCB1 and metabolic reprogramming
Zhuojia Chen et al.
THERANOSTICS (2020)
Discovery of Small Molecules that Activate RNA Methylation through Cooperative Binding to the METTL3-14-WTAP Complex Active Site
Simona Selberg et al.
CELL REPORTS (2019)
The role of m6A RNA methylation in cancer
Ting Sun et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Small-Molecule Targeting of Oncogenic FTO Demethylase in Acute Myeloid Leukemia
Yue Huang et al.
CANCER CELL (2019)
The role of m6A RNA methylation in human cancer
Xiao-Yu Chen et al.
MOLECULAR CANCER (2019)
Identification of entacapone as a chemical inhibitor of FTO mediating metabolic regulation through FOXO1
Shiming Peng et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
m6A mRNA demethylase FTO regulates melanoma tumorigenicity and response to anti-PD-1 blockade
Seungwon Yang et al.
NATURE COMMUNICATIONS (2019)
Resveratrol and Curcumin Improve Intestinal Mucosal Integrity and Decrease m6A RNA Methylation in the Intestine of Weaning Piglets
Zhending Gan et al.
ACS OMEGA (2019)
m6A modification-mediated CBX8 induction regulates stemness and chemosensitivity of colon cancer via upregulation of LGR5
Yi Zhang et al.
MOLECULAR CANCER (2019)
Betaine increases mitochondrial content and improves hepatic lipid metabolism
Lifang Zhang et al.
FOOD & FUNCTION (2019)
Chinese Herbal Medicine Wenxia Changfu Formula Reverses Cell Adhesion-Mediated Drug Resistance via the Integrin beta 1-PI3K-AKT Pathway in Lung Cancer
YaNan Zhang et al.
JOURNAL OF CANCER (2019)
Essential role of METTL3-mediated m6A modification in glioma stem-like cells maintenance and radioresistance
A. Visvanathan et al.
ONCOGENE (2018)
Baicalin hydrate inhibits cancer progression in nasopharyngeal carcinoma by affecting genome instability and splicing
Weiwei Lai et al.
ONCOTARGET (2018)
R-2HG Exhibits Anti-tumor Activity by Targeting FTO/m6A/MYC/CEBPA Signaling
Rui Su et al.
CELL (2018)
Herbal formula Huang Qin Ge Gen Tang enhances 5-fluorouracil antitumor activity through modulation of the E2F1/TS pathway
Haizhou Liu et al.
CELL COMMUNICATION AND SIGNALING (2018)
Epigallocatechin gallate targets FTO and inhibits adipogenesis in an mRNA m6A-YTHDF2-dependent manner
Ruifan Wu et al.
INTERNATIONAL JOURNAL OF OBESITY (2018)
FTO regulates the chemo-radiotherapy resistance of cervical squamous cell carcinoma (CSCC) by targeting -catenin through mRNA demethylation
Shun Zhou et al.
MOLECULAR CARCINOGENESIS (2018)
Zc3h13 Regulates Nuclear RNA m6A Methylation and Mouse Embryonic Stem Cell Self-Renewal
Jing Wen et al.
MOLECULAR CELL (2018)
A dynamic N-6-methyladenosine methylome regulates intrinsic and acquired resistance to tyrosine kinase inhibitors
Fei Yan et al.
CELL RESEARCH (2018)
Cancer Treatment by Using Traditional Chinese Medicine Probing Active Compounds in Anti-multidrug Resistance During Drug Therapy
Jian-Shu Lou et al.
CURRENT MEDICINAL CHEMISTRY (2018)
The therapeutic potential of targeting ABC transporters to combat multi-drug resistance
Piyush Bugde et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2017)
RNA m6A methylation regulates the ultraviolet-induced DNA damage response
Yang Xiang et al.
NATURE (2017)
N6-methyladenosine alters RNA structure to regulate binding of a low-complexity protein
Nian Liu et al.
NUCLEIC ACIDS RESEARCH (2017)
A Novel IMP1 Inhibitor, BTYNB, Targets c-Myc and Inhibits Melanoma and Ovarian Cancer Cell Proliferation
Lily Mahapatra et al.
TRANSLATIONAL ONCOLOGY (2017)
Sulforaphane-Induced Cell Cycle Arrest and Senescence are accompanied by DNA Hypomethylation and Changes in microRNA Profile in Breast Cancer Cells
Anna Lewinska et al.
THERANOSTICS (2017)
A Novel Inhibitor of the Obesity-Related Protein FTO
Yan Qiao et al.
BIOCHEMISTRY (2016)
RNA helicase YTHDC2 promotes cancer metastasis via the enhancement of the efficiency by which HIF-1α mRNA is translated
Atsushi Tanabe et al.
CANCER LETTERS (2016)
Nuclear m6A Reader YTHDC1 Regulates mRNA Splicing
Wen Xiao et al.
MOLECULAR CELL (2016)
Cellular Pathways in Response to Ionizing Radiation and Their Targetability for Tumor Radiosensitization
Patrick Maier et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Identification of A Novel Small-Molecule Binding Site of the Fat Mass and Obesity Associated Protein (FTO)
Wu He et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Meclofenamic acid selectively inhibits FTO demethylation of m(6)A over ALKBH5
Yue Huang et al.
NUCLEIC ACIDS RESEARCH (2015)
Herbal medicine Guan Chang Fu Fang enhances 5-fluorouracil cytotoxicity and affects drug-associated genes in human colorectal carcinoma cells
Chen Yu et al.
ONCOLOGY LETTERS (2015)
Development of Cell-Active N6-Methyladenosine RNA Demethylase FTO Inhibitor
Baoen Chen et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2012)
The Herb Medicine Formula Chong Lou Fu Fang Increases the Cytotoxicity of Chemotherapeutic Agents and Down-Regulates the Expression of Chemotherapeutic Agent Resistance-Related Genes in Human Gastric Cancer Cells In Vitro
Yongping Liu et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2011)
Pharmacological effects of serum containing Chinese medicine Bushen Huayu Jiedu compound recipe in lung cancer drug-resistance cells
Cao Yong et al.
CHINESE JOURNAL OF INTEGRATIVE MEDICINE (2008)